Kronox Lab Sciences Ltd (KRONOX) — shareholding pattern, promoter holding, financials and share price

At ₹151.1 a share on 10 Jul 2026, Kronox Lab Sciences Ltd (KRONOX) was valued at a price-to-earnings ratio of 20.35x against an industry P/E of 45.11x and a price-to-book of 6.22x on a book value of ₹24.28 per share as of Mar 2025. Solomo computes return on equity of 30.58% and return on capital employed of 41.41% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.

P/E

20.35x

Industry P/E

45.11x

P/B

6.22x

EPS (TTM)

₹7.43

Book value / share

₹24.28

ROE

30.58%

ROCE

41.41%

ROA

27.88%

Debt / equity

0x

Dividend yield

0.33%

EBITDA margin

38.89%

52-week range

₹96 – ₹196.05

Ratios are computed from filed results and the last recorded price. Not investment advice.

In the year ended Mar 2026, Kronox Lab Sciences Ltd (KRONOX) reported revenue of ₹101 crore, net profit of ₹28 crore and earnings per share of ₹7.45. That compares with revenue of ₹100 crore and net profit of ₹25 crore in Mar 2025. Figures are standalone, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹26.13 crore and net profit ₹8 crore (standalone).